Although CPA elicits immune responses, overall immunity, particularly cell-mediated immunity, is considered suboptimal (107), suggesting that cell-mediated effector products (e.g., IFN-γ) may be altered in CPA (2), with additional complexity introduced by underlying COPD. The gene discussed is IFNG; the disease is chronic obstructive pulmonary disease.